Found: 1
Select item for more details and to access through your institution.
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 455, doi. 10.1007/s10549-021-06276-7
- By:
- Publication type:
- Article